Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins

Journal of Medical Virology

Volumn 70, Issue 3, 2003, Pages 361-372

  Shaw, Megan L ^a,d   McLauchlan, John ^b   Mills, Peter R ^c   Patel, Arvind H ^b   McCruden, Elizabeth A B ^a,b,c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b INSTITUTE OF VIROLOGY   (United Kingdom)

^c GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

CD81; HCV genotypes 1 and 3; SFV expression system

Indexed keywords

COMPLEMENTARY DNA; INTERFERON; MONOCLONAL ANTIBODY; POLYPROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CROSS REACTION; DRUG RESPONSE; ENDOPLASMIC RETICULUM; GENE EXPRESSION; GENE LOCATION; GENE SEQUENCE; GENETIC CODE; GENOTYPE; GLYCOSYLATION; HEPATITIS C; HEPATITIS C VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN CONFORMATION; PROTEIN INTERACTION; RNA EXTRACTION; SEQUENCE ANALYSIS; STEATOSIS; VIRUS ENVELOPE; VIRUS GENE; VIRUS PATHOGENESIS; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; CELL LINE; CRICETINAE; ENDOPLASMIC RETICULUM; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENOTYPE; GLYCOSYLATION; HEPACIVIRUS; HEPATITIS C ANTIGENS; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, VIRUS; SEQUENCE ALIGNMENT; VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS; RABBIT FIBROMA VIRUS; STAPHYLOCOCCUS PHAGE 3A;

EID: 0038700761     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10404     Document Type: Article

References (34)

1. Clayton RF, Owsianka A, Aitken J, Graham S, Bhella D, Patel AH. 2002. Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles. J Virol 76:7672-7682.
2. Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, Mosca M, Filliponi F, Brunetto RM, Bonino F, Abrignani S, Valiante NM. 2002. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 195:35-41.
3. Deleersnyder V, Pillez A, Wychowski C, Blight K, Xu J, Hahn YS, Rice CM, Dubuisson J. 1997. Formation of native hepatitis C virus glycoprotein complexes. J Virol 71:697-704.
4. Dubuisson J, Rice CM. 1996. Hepatitis C virus glycoprotein folding: disulphide bond formation and association with calnexin. J Virol 70:778-786.
5. Dubuisson J, Hsu HH, Cheung RC, Greenberg HB, Russell DG, Rice CM. 1994. Formation and intracellular localisation of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol 68:6147-6160.
6. Flint M, Maidens C, Loomis-Price LD, Shotton C, Dubuisson J, Monk P, Higginbottom A, Levy S, McKeating JA. 1999. Characterisation of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol 73:6235-6244.
7. Gavel Y, von Heijne G. 1990. Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering. Protein Eng 3:433-442.
8. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM. 1993. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67:1385-13895.
9. Hadlock KG, Lanford RE, Perkins S, Rowe J, Yang Q, Levy S, Pileri P, Abrignani S, Foung SKH. 2000. Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognise conserved conformational epitopes. J Virol 74:10407-10416.
10. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K. 1991. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci USA 88:5547-5551.
11. Hussy P, Langen H, Mous J, Jacobsen H. 1996. Hepatitis C virus core protein: carboxy-terminal boundaries of two processed species suggest cleavage by a signal peptide peptidase. Virology 224:93-104.
12. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:570-574.
13. Liljestrom P, Garoff H. 1991. A new generation of animal cell expression vectors based on the semliki forest virus replicon. Biotechnology 9:1356-1361.
14. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, Benhamou JP, Erlinger S. 1995. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alpha therapy in chronic hepatitis. Hepatology 22:1050-1056.
15. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK. 1998. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339:1485-1492.
16. McKechnie VM, Mills PR, McCruden EA. 2000. The NS5a gene of hepatitis C virus in patients treated with interferon-alpha. J Med Virol 60:367-378.
17. McLauchlan J, Lemberg M, Hope G, Martoglio B. 2002. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J 21:1-9.
18. Meola A, Sbardellati A, Bruni Ercole B, Cerretani M, Pezzanera M, Ceccacci A, Vitelli A, Levy S, Nicosia A, Traboni C, McKeating J, Scarselli E. 2000. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. J Virol 74:5933-5938.
19. Meunier JC, Fournillier A, Choukhi A, Cahour A, Cocquerel L, Dubuisson J, Wychowski C. 1999. Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex. J Gen Virol 80:887-896.
20. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H, Mishiro S. 1993. Characterisation of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 74:2385-2390.
21. Owsianka A, Clayton RF, Loomis-Price LD, McKeating JA, Patel AH. 2001. Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. J Gen Virol 82:1877-1883.
22. Patel J, Patel A, McLauchlan J. 1999. Covalent interactions are not required to permit or stabilise the non-covalent association of hepatitis C virus glycoproteins E1 and E2. J Gen Virol 80:1681-2883.
23. Patel AH, Wood J, Penin F, Dubuisson J, McKeating JA. 2000. Construction and characterisation of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding. J Gen Virol 81:2873-2883.
24. Patel J, Patel A, McLauchlan J. 2001. The transmembrane domain of the hepatitis C virus E2 glycoprotein is required for correct folding of the E1 glycoprotein and native complex formation. Virology 279:58-68.
25. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. 1998. Binding of hepatitis C virus to CD81. Science 282:938-941.
26. Rubbia-Brandt L, Leandro G, Spahr L, Giostra E, Quadri R, Male PJ, Negro F. 2001. Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3. Histopathology 39:119-124.
27. Smith DB, McAllister J, Casino C, Simmonds P. 1997. Virus "quasispecies": making a mountain out of a molehill? J Gen Virol 78:1511-1519.
28. Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285:107-110.
29. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
30. Tseng C-TK, Klimpel GR. 2001. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 195:43-50.
31. Yagnik AT, Lahm A, Meola A, Roccasecca RM, Ercole BB, Nicosia A, Tramontano A. 2000. A model for the hepatitis C virus envelope glycoprotein E2. Proteins 40:355-366.
32. Yanagi M, Purcell RH, Emerson SU, Bukh J. 1997. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci USA 94:8738-8743.
33. Yi M, Nakamoto Y, Kaneko S, Yamashita T, Murakami S. 1997. Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2. Virology 231:119-129.
34. Zeuzem S, Feinman SV, Rasenack J, Heathcote EJ, Lai MY, Gane E, O'Grady J, Reichen J, Diago M, Lin A, Hoffman J, Brunda MJ. 2000. Peginterferon alpha-2a in patients with chronic hepatitis C. N Engl J Med 343:1666-1672.